C12Y 113/12
Oxidoreductases acting on single donors with incorporation of molecular oxygen: with incorporation
Official title: with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
C12Y113/12 (Oxidoreductases acting on single donors with incorporation of molecular oxygen: with incorporation) appears on 350 US grants and 548 published applications in this corpus.
Search patents in C12Y- Granted patents
- 350
- Published applications
- 548
- Assignees
- 191
- Inventors
- 748
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 3 | 0 |
| 1994 | 4 | 0 |
| 1995 | 1 | 0 |
| 1996 | 4 | 0 |
| 1997 | 6 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 4 | 0 |
| 2001 | 4 | 0 |
| 2002 | 2 | 0 |
| 2003 | 1 | 5 |
| 2004 | 2 | 3 |
| 2005 | 1 | 8 |
| 2006 | 3 | 1 |
| 2007 | 3 | 18 |
| 2008 | 1 | 17 |
| 2009 | 10 | 14 |
| 2010 | 14 | 14 |
| 2011 | 8 | 11 |
| 2012 | 8 | 13 |
| 2013 | 4 | 9 |
| 2014 | 9 | 48 |
| 2015 | 20 | 36 |
| 2016 | 28 | 41 |
| 2017 | 30 | 38 |
| 2018 | 27 | 44 |
| 2019 | 34 | 48 |
| 2020 | 30 | 36 |
| 2021 | 16 | 20 |
| 2022 | 15 | 29 |
| 2023 | 20 | 24 |
| 2024 | 8 | 22 |
| 2025 | 12 | 21 |
| 2026 | 12 | 28 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 113/12007Photinus-luciferin 4-monooxygenase , i.e. firefly-luciferase280
- C12Y 113/12005Renilla-luciferin 2-monooxygenase , i.e. renilla-luciferase51
- C12Y 113/12013Oplophorus-luciferin 2-monooxygenase19
- C12Y 113/12004Lactate 2-monooxygenase10
- C12Y 113/12009Phenylalanine 2-monooxygenase3
- C12Y 113/12001Arginine 2-monooxygenase2
- C12Y 113/12006Cypridina-luciferin 2-monooxygenase , i.e. cypridina-luciferase2
- C12Y 113/12002Lysine 2-monooxygenase1
All 15 subgroupsShow fewer
- C12Y 113/12003Tryptophan 2-monooxygenase1
- C12Y 113/12016Nitronate monooxygenase1
- C12Y 113/120192-oxuglutarate dioxygenase1
- C12Y 113/12008Watasenia-luciferin 2-monooxygenase0
- C12Y 113/120153,4-dihydroxyphenylalanine oxidative deaminase0
- C12Y 113/12017Dichloroarcyriaflavin a synthase0
- C12Y 113/12018Dinoflagellate luciferase0
Recent patents
- Pathogen detection method and apparatus7 Jul 2026US 12,674,798 B2Industry-Academic Cooperation Foundation, Yeungnam University
- Lipids and lipid nanoparticle formulations for delivery of nucleic acids30 Jun 2026US 12,667,627 B2Acuitas Therapeutics, Inc.
- Multipartite luciferase16 Jun 2026US 12,655,398 B2Promega Corporation
- DNA vaccines16 Jun 2026US 12,655,477 B2Touchlight IP Limited
- Detection of environmental influences by bioluminescence2 Jun 2026US 12,644,104 B2Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen
- Genetically engineered cd4 t-cells for in situ synthesis of proteins8 Oct 2026US 2026/0308515 A1SRI International
- Photoswitch protein8 Oct 2026US 2026/0308556 A1Kanagawa Institute of Industrial Science and Technology
- Modified rna with decreased immunostimulatory properties24 Sep 2026US 2026/0284227 A1CureVac AG
- Fully genetically encoded nad+protein probe based on resonance energy transfer,and preparation method therefor and use thereof17 Sep 2026US 2026/0275323 A1Shenzhen Institutes of Advanced Technology
- Engineered Luciferases and Luciferin Substrates27 Aug 2026US 2026/0250737 A1Monod Bio, Inc.
Most cited
By later US patents
- Delivery of exogenous DNA sequences in a mammal1,218US 5,580,859 AVical Incorporated · 1996
- Induction of a protective immune response in a mammal by injecting a DNA sequence885US 5,589,466 AVical Incorporated · 1996
- Generation of antibodies through lipid mediated DNA delivery427US 5,703,055 AVical Incorporated · 1997
- Induction of a protective immune response in a mammal by injecting a DNA sequence362US 6,214,804 B1Vical Incorporated · 2001
- DNA sequences encoding coleoptera luciferase activity233US 5,674,713 AThe Regents of the University of California · 1997